期刊文献+

人胰高血糖素样肽-1 cDNA的克隆与表达 被引量:7

Cloning and expression of human glucagon-like peptide-1 cDNA
下载PDF
导出
摘要 目的 :克隆人胰高血糖素样肽 - 1(h GL P- 1) c DNA,构建原核表达质粒 p GEX- 4T- 3/ h GL P- 1c DNA,并诱导表达谷胱甘肽巯基转移酶 - h GL P- 1(GST- h GL P- 1)融合蛋白。方法 :采用亚磷酸二酯法合成 6个 h GL P- 1c DNA的寡核苷酸片段 ,拼接成完整的 h GL P- 1c DNA ,克隆至 p BS SK(+ / - )载体中 ,经双酶切鉴定和测序后把 h GL P- 1c DNA定向插入融合基因表达载体 p GEX- 4T- 3的多克隆位点上 ,构建重组质粒 p GEX- 4T- 3/ h GL P- 1c DNA,并转化大肠杆菌 TG1。 结果 :经限制性内切酶Bam H 、Xho 酶切和电泳 ,证明 h GL P- 1c DNA已插入到 p GEX- 4T- 3中并诱导表达出融合蛋白。结论 :成功诱导表达出融合蛋白 GST- h GL P- 1,为进一步获得大量可供实验研究和临床应用的重组 h GL P- 1创造条件。 Objective: To clone hGLP 1 cDNA in the pBS SK(+/-)vector and construct the expression vector of pGEX 4T 3/hGLP 1cDNA to express GST hGLP 1 fusion protein. Methods: The hGLP 1 cDNA was constructed by 6 synthetic oligonucleotides fragments, followed by the procedure of annealing and ligation with oligonucleotides fragments. The hGLP 1 cDNA was cloned into the pBS SK(+/-) vector, and was selected by α complementation. It was confirmed by DNA sequening, then inserted into the MCS of the fusion expression vector pGEX 4T 3. The recombinant vector was transformed into E. coli TG1. Results: The recombinant plasmid DNA was digested with restrictive endonuclease BamHⅠand XhoⅠ. The result demonstrated that the hGLP 1 cDNA was successfully inserted into the pGEX 4T 3 vector and fusion protein GST hGLP 1 had been expressed in SDS PAGE. Conclusion: Expression of GST hGLP 1 fusion protein can provide foundation for obtaining a larger quantity of recombinant hGLP 1 for experimental and clinic studies. [
出处 《第二军医大学学报》 CAS CSCD 北大核心 2001年第4期316-318,共3页 Academic Journal of Second Military Medical University
基金 国家自然科学基金!资助项目 (39870 170 )
关键词 胰高血糖素样肽-1 克隆 分子 基因表达 糖尿病 CDNA glucagon like peptide 1 cloning,molecular gene expression diabetes mellitus
  • 相关文献

参考文献3

  • 1萨姆布鲁克J 弗里奇EF.分子克隆实验指南(第2版)[M].北京:科学出版社,1995.565-571.
  • 2Sandhu H,Diabetes,1999年,48卷,5期,1045页
  • 3金冬雁(译),分子克隆实验指南(第2版),1995年,908页

共引文献17

同被引文献85

  • 1尹晓敏,施建华,刘飞.剪接因子SRp55原核表达质粒的构建和表达[J].南通大学学报(医学版),2007,27(2):79-82. 被引量:1
  • 2[1]Vilsboll T,Krarup T,Madsbad S,et al.No reactive hypo-glycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose[J].Diabet Med,2001,18(2):144-149.
  • 3[3]De L,Diva D,Deng SP,et al.Role of endogenous glucagons-like peptide-1 in islet regeneration after partial pancreatectomy[J].Diabetes,2003,52(2):365-371.
  • 4[4]Zander M,Medsbad S,Madsen JL,et al.Effect of 6-week course of glucagons-like peptide-1 on glycaemic control,insulin sensitivity,and β-cell function in type 2 diabetes:as parallel -group study[J].Lancet,2002,359(9309):824-830.
  • 5[5]Neumiller JJ,Odegard PS,White JR Jr,et al,looking to the future:focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapies[J].Diabetes Edu-cation,2008,34(2):183-200.
  • 6[7]Green BD,Gault VA,O'harte FP,et al.Structurally modi-fied analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as fu-ture antidiabetic agents[J].Curr Pharm Des,2004,10(29):3651-3662.
  • 7[8]Gallwitz B,Ropeter T,Morys-Wortmann C,et al.GLP-1-analogues resistant to degradation by dipeptidyl-peptidase Ⅳ in vitro[J].Regul Pept,2000,86(1-3):103-111.
  • 8[9]Green BD,Mooney MH,Gault VA,et al.N-terminal His(7)-modification of glucagon-like peptide-1 (7-36) amide generates dipeptidyl peptidase Ⅳ-stable analogues with potent antihyperglycaemie activity[J].Journal of En-docrinology,2004,180(3):379-388.
  • 9Adams SH, Won WB, Schonhoff SE, et al. Effects of peptideYY(3 -36) on short-term food intake in mice are not affected by prevailing plasma ghrelin levels [ J ]. Endocrinology, 2004,145:4967 - 4975.
  • 10Aponte GW, Fink AS, Meyer JH, et al. Regional distribution and release of peptide YY with fatty acids of different chain length[ J]. Am J Physiol Gastrointest Liver Physiol, 1985, 249:745 - 750.

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部